Individualized Tamoxifen Dose Escalation-Letter

Clin Cancer Res. 2016 Dec 15;22(24):6300. doi: 10.1158/1078-0432.CCR-16-1967.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents, Hormonal*
  • Dose-Response Relationship, Drug
  • Humans
  • Tamoxifen*

Substances

  • Antineoplastic Agents, Hormonal
  • Tamoxifen